Lonza expands for two contracts
Submitted by:
Andrew Warmington
Lonza has extended two ongoing collaborations with unnamed major biopharmaceutical companies. One covers the commercial-scale
Venator emerges from Chapter 11
Submitted by:
Andrew Warmington
Venator Materials has completed its Chapter 11 recapitalisation process and claims to have “emerged with
Sterling buys UK CRO
Submitted by:
Andrew Warmington
CDMO Sterling Pharma Solutions has acquired UK-based NewChem Technologies, which offers contract services focused on
Quantum dot pioneers win Nobel Prize
Submitted by:
Andrew Warmington
The Royal Swedish Academy of Sciences has awarded the Nobel Prize in Chemistry 2023 to
Five trends in mechanical process engineering
Submitted by:
Andrew Warmington
Dr Hans-Joachim Jacob, senior expert - process & applications, at Ystral, looks at
ICCM5 adopts new framework
Submitted by:
Andrew Warmington
The Fifth International Conference on Chemicals Management (ICCM5) concluded on 30 September in Bonn, Germany
Orion opens battery centre
Submitted by:
Andrew Warmington
Orion has opened its new Battery Innovation Centre at it main innovation hub in Cologne
ACC criticises ‘regulatory overreach’
Submitted by:
Andrew Warmington
The American Chemistry Council (ACC) has launched an initiative called ‘Chemistry Creates, America Competes’. This
Elementis in war of words with investor
Submitted by:
Andrew Warmington
Speciality chemicals company Elementis has come under pressure after an investor, Franklin Mutual Advisers, published
New investor for Glemark Life Sciences
Submitted by:
Andrew Warmington
Subject to regulatory approval, Glenmark Pharma has agreed to sell a 75% stake in its